ArticleResearch in nursing & health2026
Role of Sleep Disturbances and Diabetes-Related Distress on Glycemic Control: A Path Analysis.
Article in Research in nursing & health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Despite advancements in diabetes management technology, many patients with type 2 diabetes (T2D) struggle to achieve optimal glycemic control. Sleep disorders such as obstructive sleep apnea (OSA) and insomnia are common in T2D and linked to poor glycemic control. Insomnia, particularly with short sleep duration, may worsen glycemic control by increasing diabetes-related distress. To improve glucose management, the association among sleep duration, insomnia severity, diabetes-related distress, and glycemic control needs to be further evaluated. A path analysis was conducted using data from 237 adults with T2D and OSA from the total of 406 participants who completed the baseline assessment in the Diabetes Sleep Treatment Trial (DSTT; N = 351) and the Diabetes Sleep Treatment Trial for Insomnia (DSTT-I; N = 55). Parent studies were conducted from July 2013 to June 2018 (DSTT) and from April 2017 to March 2020 (DSTT-I). Sleep duration was assessed using the Pittsburgh Sleep Quality Index, insomnia severity using the Insomnia Severity Index, and diabetes-related distress using the Problem Areas in Diabetes. Glycemic control was measured by hemoglobin A1c. The results showed that shorter sleep duration indirectly worsened glycemic control by increasing insomnia severity, which, in turn, elevated diabetes-related distress after controlling for obstructive sleep apnea severity, age, sex, marital status, race, education level, and financial difficulty. These findings suggest that sleep duration may be a modifiable factor for improving insomnia severity, reducing diabetes-related distress, and enhancing glycemic control in T2D. Optimizing sleep duration as part of clinical diabetes management may help improve glucose regulation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.